Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs

Radiation Research · Published 2026-03-25 · DOI 10.1667/rade-25-00203.1

Authors being retrieved — see the publisher record. https://doi.org/10.1667/rade-25-00203.1

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• TSPAN8-mediated Epithelial-mesenchymal Transition Drives Acquired Radioresistance in Cervical Cancer · Radiation Research · 2026 · Same journal
• Repurposing Quetiapine as an Adjuvant Therapeutic Agent for Triple-Negative Breast Cancer · Radiation Research · 2026 · Same journal
• Low-Dose Ionizing Radiation Modulates Translation Efficiency in Human Lung Fibroblasts · Radiation Research · 2026 · Same journal
• A Novel Bioluminescence Tomography System Compatible with CBCT-Guided Small Animal Irradiators for High-Precision Preclinical Radiation Research · Radiation Research · 2026 · Same journal
• Dear Colleagues and Readers of Radiation Research · Radiation Research · 2026 · Same journal
• Molecular Mechanisms of FLASH Radiotherapy in Alleviating Lung Normal Tissue Injury: Insights from Single-Cell Sequencing · Radiation Research · 2026 · Same journal
• The FLASH Effect in 3D and 2D Models: Preserving Tumor Control while Reducing Apoptosis in Normal Cells · Radiation Research · 2026 · Same journal
• Cataracts in Atomic-bomb Survivors More than 70 Years after Radiation Exposure · Radiation Research · 2026 · Same journal
• Investigating the Toxicity and Biodistribution of Boron-loaded Liposomes in Canine and Feline Models · Radiation Research · 2026 · Same journal
• Low-Dose Ionizing Radiation Modulates Translation Efficiency in Human Lung Fibroblasts · Radiation Research · 2026 · Same journal